| REVIEW ARTICLE |
|
| Year : 2023 | Volume
: 12
| Issue : 1 | Page : 20 |
|
|
Nonsteroidal anti-inflammatory drugs in viral infections disease, specially COVID-19
Narges Chamkouri, Forouzan Absalan, Zahra Koolivand, Mahsa Yousefi
Medical Faculty, Abadan University of Medical Sciences, Abadan, Iran
Correspondence Address:
Dr. Forouzan Absalan
Medical Faculty, Abadan University of Medical Sciences, Abadan
Iran
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/abr.abr_148_21
|
|
|
During the current SARS-CoV-2 (COVID-19) pandemic, some reports were presented based on those nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids may exacerbate symptoms in COVID-19 patients. According to this, we aimed to collate information available in published articles to identify any evidence behind these statements with the aim of helping clinicians on how best to treat patients. We could not find published conclusive evidence for or against the use of NSAIDs in COVID-19 patients. Meanwhile, there appeared to be some evidence that corticosteroids may be beneficial if utilized in the early acute phase of infection, however, conflicting WHO (World Health Organization) evidence surrounding corticosteroid use in certain viral infections means this evidence is not conclusive. Given the current availability of literature, caution should be exercised until further evidence emerges surrounding the use of NSAIDs and corticosteroids in COVID-19 patients. However, the availability of reliable information for clinicians and patients is paramount.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
